News Archives - Page 237 of 735

ThursdayNov 17, 2022 9:45 am

New Market Opportunities May Open up for Reklaim Ltd. (TSX.V: MYID) (OTCQB: MYIDF) as a Cookie-less Future Fast Approaches

The online advertising ecosystem is transforming as governments worldwide ramp up regulations to rein in collection of consumers' personal data Google's Privacy Sandbox works toward the end of third-party cookies in Chrome, giving rise to a whole new privacy-compliant identity ecosystem As a company driven by the evolution of data privacy and its impact on consumers and companies, Reklaim appears well-positioned to capitalize on emerging market opportunities amid a paradigm shift happening with new privacy laws User privacy is taking the online space by storm as consumers become increasingly conscious about how their online data is harvested and used. As…

ThursdayNov 17, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Approved to Proceed with Human Study Evaluating Effectiveness of Patented DehydraTECH(TM) Technology in Boosting Oral-Tissue Absorption of Nicotine

Lexaria Bioscience recently received Independent Review Board approval for its upcoming human clinical nicotine study, NIC-H22-1, and expects to begin dosing soon The company hopes to evidence that processing purified nicotine with its patented DehydraTECH(TM) drug delivery technology leads to better oral-tissue absorption and reduced negative experiences compared to leading brands currently available on the market, On! and Zyn Last year, Lexaria conducted an animal study evaluating oral nicotine absorption, NIC-A21-1, in which it evidenced that its DehydraTECH technology was ten to twenty times faster in delivering comparable levels of nicotine into the bloodstream than the peak of the concentration-matched…

WednesdayNov 16, 2022 9:45 am

EverGen Infrastructure Corp.’s (TSX.V: EVGN) (OTCQX: EVGIF) FVB Expansion Project Breaks Ground to Provide Lift to Company’s Revenues and EBITDA Amid a Stronger Renewable Natural Gas Market

EverGen commenced construction at its Core RNG Expansion Project at Fraser Valley Biogas; project is advancing on schedule and on budget with expected completion in Q1 2023 Expansion is estimated to double FVB’s capacity to ~160,000 GJ of RNG per year; coupled with new long-term offtake agreement executed in current robust RNG market, it is expected to provide significant boost to company’s revenues and EBITDA As Canada’s early mover, EverGen seeks to consolidate assets across the country and leverage its expertise in designing and optimizing resilient facilities; with team that has seen more than a hundred RNG projects, company boasts…

WednesdayNov 16, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) CEO Participated in The American Brain Tumor Association’s Breakthrough for Brain Tumors(R) 5K Run Following European Clinical Trial Site Activations

CNS Pharmaceuticals CEO John Climaco participated in 5K run on November 5, to show support for brain tumor patients worldwide and help raise funds for research The company recently announced European clinical trial site activations for its potentially pivotal global trial evaluating Berubicin for the treatment of recurring glioblastoma multiforme The pivotal trial will study Berubicin’s results compared to the current study of care, Lomustine Global brain tumor treatment market was valued at $2,946 million in 2022 and is expected to grow to $5,904 million by 2032 Brain and other central nervous system cancers (“CNS”) represent 1.3% of all new…

TuesdayNov 15, 2022 9:45 am

Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) Is ‘One to Watch’

Arizona Metals owns 100% of two copper and gold exploration projects in mining-friendly Arizona Both projects have excellent infrastructure, including roads, available power and water access Only 3% of the prospectively mineralized trend that hosts the high-grade Kay Mine Deposit has been drilled The company had $60 million in cash as of June 30, 2022, to complete Phase 2 and begin Phase 3 drilling at the Kay Mine Arizona Metals (TSX: AMC) (OTCQX: AZMCF) is a mineral exploration company engaged in advancing precious and base metal deposits in the state of Arizona. Its flagship copper-gold-zinc-silver asset is the Kay Mine…

TuesdayNov 15, 2022 9:00 am

Correlate Infrastructure Partners Inc. (CIPI) Offering Affordable and Profitable ESG-Related Energy Solutions Amid Spike in ESG-Focused Investment

In 2021, a third of the world’s assets under management, including the money of growing numbers of huge public pension funds, were invested according to ESG principles, with the year posting the highest expenditure on ESG initiatives globally Correlate recognizes the growing need for businesses to achieve ESG goals and is looking to meet this demand by offering a complete suite of proprietary clean energy assessment solutions, specifically for the commercial real estate industry Its unique data-driven approach draws from proprietary analytics, concierge subscription services, and a highly scalable national fulfillment network that has earned it an opportunity pipeline of…

MondayNov 14, 2022 12:00 pm

Coyuchi Inc. Targets Conscious Consumers with Superior Sustainable Products; Company Reviewed by Investor Analyst News Publication KingsCrowd

Coyuchi is currently accepting investments under its Regulation A+ offering and is approaching the $1 million milestone KingsCrowd has published a review on Coyuchi, highlighting the company’s strengths and future industry challenges to be met The report discusses how few individuals are better suited to run a sustainable company than CEO Eileen Mockus, given her background in working in the sustainable fabrics industry Research shows that more consumers are drawn to products that offer sustainability, and will pay more for those products over name brands Coyuchi, an organic luxury bed, bath, and apparel company setting the gold standard for sustainably…

MondayNov 14, 2022 11:15 am

Vision Energy Corp. (VIHDD) Is ‘One to Watch’

Vision Energy in October 2022 announced it had completed conceptual layouts for its Green Energy Hub project in Vlissingen, the Netherlands The company in September 2022 announced its commitment to an additional 5.19 acres, expanding its Green Energy Hub project footprint to a total of 40.53 acres Vision Energy is on schedule to file for the remaining construction and environmental permits for its Green Energy Hub project by December 2022 Current hydrogen demand projections for northwest Europe outstrip scheduled production for the next five to 10 years Vision Energy (OTCQB: VIHDD) (“Vision Energy”) is a forward-looking energy company developing carbon…

MondayNov 14, 2022 10:30 am

Odyssey Health, Inc. (ODYY) Focuses on Medical Devices Market with US Patent Application on Breath-Propelled Intranasal Delivery Device

Odyssey filed for US and global patent protection on its novel breath-propelled, intranasal brain-drug delivery device that effectively deposits concentrated drug deep into the nasal cavity for the treatment of CNS injury disease or disorder The application follows the successful completion of the second Cohort of Odyssey’s Phase I MAD clinical trial, which saw the effective use of the device and a proven safety profile for the company’s concussion pharmaceutical treatment Michael Redmond, the company’s CEO, has expressed the company’s pleasure in the functionality of the device, citing how it provides a significant opportunity and advantage for the treatment of…

MondayNov 14, 2022 9:45 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Maintains Focus on Advancing Clinical Development Program for Lead Drug Candidate, Berubicin

In June 2020, CNS’ lead drug candidate, Berubicin, received Orphan Drug designation from the FDA. In June 2021, it received Fast Track designation following positive results from an extensive clinical study that saw 44% of the patients post a clinical response, with one Durable Complete Response With GBM having a survival rate of only 6.8% and an average length of survival of only eight months, Berubicin is showing tremendous potential, and CNS is leading the charge to find a potential treatment option for the disease CNS’ management is optimistic about its lead drug candidate and continues to explore the potential…

Site Search

Company Search

Category: News